HEADER IMMUNE SYSTEM 03-MAR-09 3GHE TITLE CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 537-10D IN COMPLEX WITH V3 PEPTIDE TITLE 2 MN COMPND MOL_ID: 1; COMPND 2 MOLECULE: FAB 537-10D, LIGHT CHAIN; COMPND 3 CHAIN: L; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: FAB 537-10D, HEAVY CHAIN; COMPND 6 CHAIN: H; COMPND 7 MOL_ID: 3; COMPND 8 MOLECULE: ENVELOPE GLYCOPROTEIN; COMPND 9 CHAIN: P; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 OTHER_DETAILS: B CELL; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 OTHER_DETAILS: B CELL; SOURCE 11 MOL_ID: 3; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 14 ORGANISM_TAXID: 11676 KEYWDS HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE PROTEIN, IMMUNE KEYWDS 2 SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR X.P.KONG,V.J.BURKE REVDAT 3 03-APR-24 3GHE 1 REMARK REVDAT 2 01-NOV-17 3GHE 1 SOURCE REMARK REVDAT 1 01-DEC-09 3GHE 0 JRNL AUTH V.BURKE,C.WILLIAMS,M.SUKUMARAN,S.S.KIM,H.LI,X.H.WANG, JRNL AUTH 2 M.K.GORNY,S.ZOLLA-PAZNER,X.P.KONG JRNL TITL STRUCTURAL BASIS OF THE CROSS-REACTIVITY OF GENETICALLY JRNL TITL 2 RELATED HUMAN ANTI-HIV-1 MABS: IMPLICATIONS FOR DESIGN OF JRNL TITL 3 V3-BASED IMMUNOGENS JRNL REF STRUCTURE V. 17 1538 2009 JRNL REFN ISSN 0969-2126 JRNL PMID 19913488 JRNL DOI 10.1016/J.STR.2009.09.012 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 18197 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 875 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2820 REMARK 3 BIN FREE R VALUE : 0.3500 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 136 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3425 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 322 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.09900 REMARK 3 B22 (A**2) : -7.32200 REMARK 3 B33 (A**2) : 0.22300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -8.43800 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.30 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.38 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.370 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 43.64 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3GHE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-MAR-09. REMARK 100 THE DEPOSITION ID IS D_1000051862. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9790 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23276 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.990 REMARK 200 RESOLUTION RANGE LOW (A) : 29.950 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 73.1 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.08500 REMARK 200 R SYM (I) : 0.08000 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.99 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 8.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.40 REMARK 200 R MERGE FOR SHELL (I) : 0.49400 REMARK 200 R SYM FOR SHELL (I) : 0.33100 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: CRYSTAL STRUCTURE OF 2557 FAB WITH V3 PEPTIDE NY5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 4000, 5% ISOPROPONAL, 0.1M REMARK 280 HEPES PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 296.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.66100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR L 210 REMARK 465 GLU L 211 REMARK 465 CYS L 212 REMARK 465 CYS H 127 REMARK 465 SER H 128 REMARK 465 ARG H 129 REMARK 465 SER H 130 REMARK 465 THR H 131 REMARK 465 SER H 132 REMARK 465 GLY H 133 REMARK 465 LYS H 214 REMARK 465 THR H 215 REMARK 465 PRO H 216 REMARK 465 THR H 217 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA L 3 121.78 174.99 REMARK 500 VAL L 51 -46.56 64.63 REMARK 500 SER L 52 26.65 -146.63 REMARK 500 ASN L 60 3.58 -66.12 REMARK 500 ALA L 84 -168.22 -172.79 REMARK 500 SER L 93 -2.35 -59.84 REMARK 500 THR L 95 138.09 -36.26 REMARK 500 TYR L 95B -31.10 74.12 REMARK 500 LEU L 106A 92.17 -57.66 REMARK 500 ASP L 151 -102.92 65.25 REMARK 500 ASN H 55 -65.77 -90.10 REMARK 500 LEU H 100C -76.64 56.55 REMARK 500 ASP H 144 71.97 41.11 REMARK 500 ASN H 155 47.17 39.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Q1J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX REMARK 900 WITH V3 PEPTIDE REMARK 900 RELATED ID: 3C2A RELATED DB: PDB REMARK 900 ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE REMARK 900 RELATED ID: 3GHB RELATED DB: PDB DBREF 3GHE P 304 320 UNP P88403 P88403_9HIV1 198 212 DBREF 3GHE L 1 212 PDB 3GHE 3GHE 1 212 DBREF 3GHE H 1 217 PDB 3GHE 3GHE 1 217 SEQRES 1 L 217 GLN SER ALA LEU THR GLN PRO ALA SER VAL SER GLY SER SEQRES 2 L 217 PRO GLY GLN SER ILE THR ILE SER CYS THR GLY THR SER SEQRES 3 L 217 THR ASP VAL ASN GLY TYR ASN TYR VAL SER TRP TYR GLN SEQRES 4 L 217 GLN TYR ALA GLY LYS ALA PRO LYS LEU ILE ILE PHE ASP SEQRES 5 L 217 VAL SER LYS ARG PRO SER GLY VAL SER ASN ARG PHE SER SEQRES 6 L 217 GLY SER LYS SER GLY ASP THR ALA SER LEU THR ILE SER SEQRES 7 L 217 GLY LEU GLN ALA GLU ASP GLU ALA ASP TYR HIS CYS SER SEQRES 8 L 217 SER TYR THR SER SER THR PRO TYR VAL LEU PHE GLY GLY SEQRES 9 L 217 GLY THR LYS LEU THR VAL LEU GLY GLN PRO LYS ALA ALA SEQRES 10 L 217 PRO SER VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU SEQRES 11 L 217 GLN ALA ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP SEQRES 12 L 217 PHE TYR PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP SEQRES 13 L 217 SER SER PRO VAL LYS ALA GLY VAL GLU THR THR THR PRO SEQRES 14 L 217 SER LYS GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR SEQRES 15 L 217 LEU SER LEU THR PRO GLU GLN TRP LYS SER HIS ARG SER SEQRES 16 L 217 TYR SER CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU SEQRES 17 L 217 LYS THR VAL ALA PRO THR THR GLU CYS SEQRES 1 H 233 GLN VAL GLN LEU VAL GLN SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 233 PRO GLY GLY SER LEU ARG LEU SER CYS VAL ALA SER GLY SEQRES 3 H 233 PHE THR PHE ASN ASN TYR TRP MET SER TRP VAL ARG GLN SEQRES 4 H 233 ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA ASN ILE LYS SEQRES 5 H 233 GLN ASP GLY ASN ASP LYS TYR TYR VAL ASP SER VAL LYS SEQRES 6 H 233 GLY ARG PHE THR ILE SER ARG ASP ASN ALA LYS ASN SER SEQRES 7 H 233 LEU PHE LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 H 233 ALA VAL TYR PHE CYS ALA ARG GLU PHE SER SER TYR THR SEQRES 9 H 233 ASP HIS LEU GLU TYR TYR TYR ASP TYR TYR TYR MET ASP SEQRES 10 H 233 VAL TRP GLY LYS GLY THR THR VAL THR VAL SER SER ALA SEQRES 11 H 233 SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO CYS SEQRES 12 H 233 SER ARG SER THR SER GLY GLY THR ALA ALA LEU GLY CYS SEQRES 13 H 233 LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SER SEQRES 14 H 233 TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS THR PHE SEQRES 15 H 233 PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SER SEQRES 16 H 233 SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR GLN SEQRES 17 H 233 THR TYR THR CYS ASN VAL ASN HIS LYS PRO SER ASN THR SEQRES 18 H 233 LYS VAL ASP LYS ARG VAL GLU LEU LYS THR PRO THR SEQRES 1 P 15 ARG LYS ARG ILE HIS ILE GLY PRO GLY ARG ALA PHE TYR SEQRES 2 P 15 ALA THR FORMUL 4 HOH *322(H2 O) HELIX 1 1 GLN L 79 GLU L 83 5 5 HELIX 2 2 SER L 121 GLN L 126 1 6 HELIX 3 3 THR L 181 HIS L 188 1 8 HELIX 4 4 THR H 28 TYR H 32 5 5 HELIX 5 5 ASP H 61 LYS H 64 5 4 HELIX 6 6 ASN H 73 LYS H 75 5 3 HELIX 7 7 ARG H 83 THR H 87 5 5 HELIX 8 8 SER H 156 ALA H 158 5 3 HELIX 9 9 SER H 187 THR H 191 5 5 HELIX 10 10 LYS H 201 ASN H 204 5 4 SHEET 1 A 5 SER L 9 GLY L 13 0 SHEET 2 A 5 THR L 102 VAL L 106 1 O THR L 105 N VAL L 11 SHEET 3 A 5 ALA L 84 TYR L 91 -1 N ALA L 84 O LEU L 104 SHEET 4 A 5 VAL L 33 GLN L 38 -1 N GLN L 38 O ASP L 85 SHEET 5 A 5 LYS L 45 ILE L 48 -1 O LYS L 45 N GLN L 37 SHEET 1 B 4 SER L 9 GLY L 13 0 SHEET 2 B 4 THR L 102 VAL L 106 1 O THR L 105 N VAL L 11 SHEET 3 B 4 ALA L 84 TYR L 91 -1 N ALA L 84 O LEU L 104 SHEET 4 B 4 VAL L 96 PHE L 98 -1 O LEU L 97 N SER L 90 SHEET 1 C 3 ILE L 19 CYS L 23 0 SHEET 2 C 3 THR L 70 ILE L 75 -1 O ALA L 71 N CYS L 23 SHEET 3 C 3 PHE L 62 SER L 67 -1 N SER L 63 O THR L 74 SHEET 1 D 4 SER L 114 PHE L 118 0 SHEET 2 D 4 ALA L 130 PHE L 139 -1 O LEU L 135 N THR L 116 SHEET 3 D 4 TYR L 172 LEU L 180 -1 O TYR L 172 N PHE L 139 SHEET 4 D 4 VAL L 159 THR L 161 -1 N GLU L 160 O TYR L 177 SHEET 1 E 4 SER L 114 PHE L 118 0 SHEET 2 E 4 ALA L 130 PHE L 139 -1 O LEU L 135 N THR L 116 SHEET 3 E 4 TYR L 172 LEU L 180 -1 O TYR L 172 N PHE L 139 SHEET 4 E 4 SER L 165 LYS L 166 -1 N SER L 165 O ALA L 173 SHEET 1 F 4 SER L 153 VAL L 155 0 SHEET 2 F 4 THR L 145 ALA L 150 -1 N ALA L 150 O SER L 153 SHEET 3 F 4 TYR L 191 HIS L 197 -1 O GLN L 194 N ALA L 147 SHEET 4 F 4 SER L 200 VAL L 206 -1 O SER L 200 N HIS L 197 SHEET 1 G 4 GLN H 3 SER H 7 0 SHEET 2 G 4 LEU H 18 SER H 25 -1 O SER H 21 N SER H 7 SHEET 3 G 4 SER H 77 MET H 82 -1 O MET H 82 N LEU H 18 SHEET 4 G 4 PHE H 67 ASP H 72 -1 N SER H 70 O PHE H 79 SHEET 1 H 6 GLY H 10 VAL H 12 0 SHEET 2 H 6 THR H 107 VAL H 111 1 O THR H 110 N GLY H 10 SHEET 3 H 6 ALA H 88 ASP H 100A-1 N TYR H 90 O THR H 107 SHEET 4 H 6 TRP H 33 GLN H 39 -1 N VAL H 37 O PHE H 91 SHEET 5 H 6 LEU H 45 ILE H 51 -1 O VAL H 48 N TRP H 36 SHEET 6 H 6 LYS H 57 TYR H 59 -1 O TYR H 58 N ASN H 50 SHEET 1 I 6 GLY H 10 VAL H 12 0 SHEET 2 I 6 THR H 107 VAL H 111 1 O THR H 110 N GLY H 10 SHEET 3 I 6 ALA H 88 ASP H 100A-1 N TYR H 90 O THR H 107 SHEET 4 I 6 TYR H 100E TRP H 103 -1 O TYR H 100I N SER H 98 SHEET 5 I 6 LYS P 305 GLY P 312 1 O ILE P 307 N ASP H 100H SHEET 6 I 6 ARG P 315 ALA P 319 -1 O PHE P 317 N HIS P 308 SHEET 1 J 4 SER H 120 LEU H 124 0 SHEET 2 J 4 THR H 135 TYR H 145 -1 O LEU H 141 N PHE H 122 SHEET 3 J 4 TYR H 176 PRO H 185 -1 O VAL H 184 N ALA H 136 SHEET 4 J 4 VAL H 163 THR H 165 -1 N HIS H 164 O VAL H 181 SHEET 1 K 4 SER H 120 LEU H 124 0 SHEET 2 K 4 THR H 135 TYR H 145 -1 O LEU H 141 N PHE H 122 SHEET 3 K 4 TYR H 176 PRO H 185 -1 O VAL H 184 N ALA H 136 SHEET 4 K 4 VAL H 169 LEU H 170 -1 N VAL H 169 O SER H 177 SHEET 1 L 3 THR H 151 TRP H 154 0 SHEET 2 L 3 THR H 195 HIS H 200 -1 O ASN H 197 N SER H 153 SHEET 3 L 3 THR H 205 ARG H 210 -1 O VAL H 207 N VAL H 198 SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.04 SSBOND 2 CYS L 134 CYS L 193 1555 1555 2.03 SSBOND 3 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 4 CYS H 140 CYS H 196 1555 1555 2.03 CISPEP 1 THR L 95 PRO L 95A 0 0.07 CISPEP 2 TYR L 140 PRO L 141 0 0.19 CISPEP 3 PHE H 146 PRO H 147 0 -0.65 CISPEP 4 GLU H 148 PRO H 149 0 -0.14 CRYST1 46.363 71.322 77.124 90.00 104.25 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021569 0.000000 0.005478 0.00000 SCALE2 0.000000 0.014021 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013378 0.00000